Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
Avadel Pharmaceuticals Net Income (TTM) : -0.278M for Sept. 30, 2025
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2025 | -0.278M |
| June 30, 2025 | -2.923M |
| March 31, 2025 | -26.41M |
| December 31, 2024 | -48.83M |
| September 30, 2024 | -72.58M |
| June 30, 2024 | -106.22M |
| March 31, 2024 | -156.83M |
| December 31, 2023 | -160.28M |
| September 30, 2023 | -158.94M |
| June 30, 2023 | -142.81M |
| March 31, 2023 | -141.82M |
| December 31, 2022 | -137.46M |
| September 30, 2022 | -132.32M |
| June 30, 2022 | -134.17M |
| March 31, 2022 | -90.31M |
| December 31, 2021 | -77.33M |
| September 30, 2021 | -66.31M |
| June 30, 2021 | -56.01M |
| March 31, 2021 | -5.552M |
| December 31, 2020 | 7.028M |
| September 30, 2020 | 15.57M |
| June 30, 2020 | 18.41M |
| March 31, 2020 | -21.07M |
| December 31, 2019 | -33.23M |
| September 30, 2019 | -94.35M |
| Date | Value |
|---|---|
| June 30, 2019 | -101.25M |
| March 31, 2019 | -96.09M |
| December 31, 2018 | -95.30M |
| September 30, 2018 | -40.71M |
| June 30, 2018 | -3.257M |
| March 31, 2018 | 29.11M |
| December 31, 2017 | 67.25M |
| September 30, 2017 | 81.25M |
| June 30, 2017 | 39.58M |
| March 31, 2017 | -9.308M |
| December 31, 2016 | -41.28M |
| September 30, 2016 | 30.09M |
| June 30, 2016 | 20.40M |
| March 31, 2016 | 22.95M |
| December 31, 2015 | 40.66M |
| September 30, 2015 | -67.32M |
| June 30, 2015 | -47.68M |
| March 31, 2015 | -51.36M |
| December 31, 2014 | -89.86M |
| September 30, 2014 | -55.51M |
| June 30, 2014 | -51.83M |
| March 31, 2014 | -63.61M |
| December 31, 2013 | -45.58M |
| September 30, 2013 | -38.95M |
| June 30, 2013 | -39.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Jazz Pharmaceuticals Plc | 940.76M |
| Perrigo Co. Plc | -1.703B |
| GH Research Plc | -62.27M |
| Cosmo NV | -7.221M |
| Alkermes Plc | 66.12M |